Ketamine
-
A new pilot study has demonstrated nitrous oxide, commonly known as laughing gas, may help military veterans suffering from PTSD. A larger trial is now underway after several studies demonstrated potential new uses for the gas. -
Scientists have discovered a new mechanism to help illustrate the rapid antidepressant qualities of ketamine. Imaging patients with depression revealed ketamine’s effects are a result of its interaction with a particular kind of serotonin receptor.
-
A study led by scientists at Yale University has described the promising early-stage results of a new drug designed to mimic the rapid antidepressant effects of ketamine, but without that drug’s dissociative psychoactive qualities. The experimental drug is currently in early phases of human testing.
-
There remains a lot to learn about ketamine and its close chemical relatives when treating depression. A new study has shed more light on how it can stave off depressive symptoms, with experiments on mice revealing how it repairs busted circuits in the brain.
-
ScienceFollowing the FDA’s approval of a ketamine-inspired nasal spray for treatment-resistant depression, new research is offering provocative insights into how the drug exerts such a rapid anti-depressant effect and points to new pathways for research into alternative drugs to treat depression.
-
ScienceThe FDA has just approved esketamine for adults with treatment-resistant depression, in a landmark announcement marking the first new major depression treatment introduced for clinical use in over 30 years. The nasal spray is a close chemical relative to the controversial anesthetic ketamine.
-
A new nasal spray for depression, utilizing a drug called esketamine, has passed the last step on its way to final FDA approval. An advisory panel to the FDA voted in favor of the new drug’s risk/benefit profile meaning the ketamine-inspired treatment may be approved for use within the next month.
-
Two new studies suggest the psychiatric benefits of ketamine treatment may extend beyond just the targeting of depression. The research demonstrates ketamine may be helpful in targeting both anxiety- and substance abuse-related depression.
-
Ketamine has become the subject of intense research in recent years, as scientists hunt for new and improved treatments for depression. A new study has highlighted some worrying parallels between ketamine and opioids, raising red flags about the potentially addictive qualities of the drug.
